Convalescent Plasma Therapy Global Market Report 2021: COVID-19 Implications And Growth To 2030

The Business Research Company’s Convalescent Plasma Therapy Global Market Report 2021: COVID-19 Implications And Growth To 2030

LONDON, GREATER LONDON, UK, April 12, 2021 /EINPresswire.com/ -- Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

Higher efficacy and safety evaluated during the trials conducted for CPT in COVID-19 patients can drive the market growth during the forecast period. Convalescent plasma transfusion has been of interest in the historical period for the treatment of other infectious disease outbreaks such as SARS-1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1. In June 2020, results of a study conducted by the Houston Methodist hospital, which aimed at evaluating safety and efficacy of COVID-19 convalescent plasma therapy, stated that the convalescent plasma therapy is safe with no adverse events reported and is efficient with 76% recovery rate. In May 2020, a study published in the Journal of Medical Virology stated that with convalescent plasma therapy, the mortality rate may be reduced in critically ill patients, beneficial effects on clinical symptoms will be observed, and an increase in neutralizing antibody titers and disappearance of SARS-CoV-2 RNA will be observed. The safety and efficacy of the convalescent plasma therapy in COVID-19 patients will boost convalescent plasma therapy (CPT) market growth.

The global convalescent plasma therapy market is expected to grow from $0.026 billion in 2020 to $0.028 billion in 2021 at a compound annual growth rate (CAGR) of 7.7%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The convalescent plasma therapy market is expected to reach $0.05 billion in 2025 at a CAGR of 16%.

Read More On The Global Convalescent Plasma Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-market-global-report-2020-30-covid-19-implications-and-growth

The convalescent plasma therapy market covered in this report is segmented by application into prophylaxis, treatment. The convalescent plasma therapy market is also segmented by end-users into hospitals & clinics, laboratories & research institutes and by antibody type into IgM, IgG, IgA.

Major players in the convalescent plasma therapy industry are Bio Farma, Grifols, Hilton Pharma, Biotest, BPL, LFB, Octapharma, CSL Behring, Takeda Pharmaceutical Company Limited, and Orthosera Kft.

Convalescent Plasma Therapy Global Market Report 2021: COVID-19 Implications And Growth To 2030 is one of a series of new reports from The Business Research Company that provides convalescent plasma therapy market overview, forecast convalescent plasma therapy market size and growth for the whole market, convalescent plasma therapy market segments, and geographies, convalescent plasma therapy market trends, convalescent plasma therapy market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Convalescent Plasma Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Plasma Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/plasma-therapy-global-market-report-2020-30-covid-19-growth-and-change

Patient Blood Management Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-change

CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/car-t-therapy-market

Interested to know more about The Business Research Company?

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn